Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-25-007283

Options or other derivatives

  • CHIEF TECHNOLOGY OFFICER acquired 254,857 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Yan Ming CHIEF TECHNOLOGY OFFICER 2025-03-04 Grant or award · Employee Stock Option (right to buy) +156,250 156,250 D
Yan Ming CHIEF TECHNOLOGY OFFICER 2025-03-04 Grant or award · Restricted Stock Units +98,607 98,607 D
Loading xslF345X05/form4-03062025_100342.xml…